Full-Time

Sr Administrative Coordinator

Posted on 6/11/2025

Deadline 7/1/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Sant Cugat del Vallès, Barcelona, Spain

On-site commitment of three days a week.

Category
Executive Support
Administrative & Executive Assistance
Administrative Support
Requirements
  • Fluency in English is required
  • HS Diploma or GED
  • 5 plus years prior Personal Assistant experience or experience supporting high-level executives within a global organization
  • Good communication skills
  • Demonstrated ability to effectively work in a global environment
  • Able to prioritize time-sensitive assignments
  • Should be able to work autonomously, and at the same time, collaborate effectively with other members of the administrative support team
  • Advanced proficiency in Microsoft Office and other web-based systems such as SPOL
  • Flexible to adapt to ever-changing needs and deadlines
  • Able to effectively work in a fast-paced environment while maintaining confidentiality and discretion
  • Ability to demonstrate tact, persuasion, and/or negotiation and maintain confidentiality
  • Must demonstrate high integrity
Responsibilities
  • Arrange multi-location domestic and international travel arrangements and expense reports with accuracy and efficiency, including follow-through to ensure that appropriate and timely action is taken. Monitor VISA’s and Passport expirations to ensure they are current.
  • Track and manage functional expenses, budget, and CO2 ensuring accuracy and timely reporting.
  • Assist with administrative and logistical aspects related to recruitment of new employees (schedules interviews, coordinates on-boarding of new staff).
  • Coordinate larger internal and external meetings/Broadcasts, including scheduling meeting times, making travel arrangements for attendees, and ensuring that various meeting amenities are available.
  • Maintain department SPOL site.
  • Maintain awareness of new systems with potential impact on administrative work and develop personal expertise in new systems.
  • Effectively manage special projects and other duties as assigned.
  • Work with leaders to help prioritize work and realize efficiencies within the team.
  • Facilitate work through contracting routes, to enable rapid SOW creation and project initiation along with purchase order creation, invoice resolution, and other financial administration.
  • Plan site-specific and virtual engagement events for the team.
  • Respond on behalf of the team to different partners while maintaining high professional standards and meeting conflicting needs. Handle more intensified or raised inquiries from other PA/administrative staff.
Desired Qualifications
  • Bachelor’s degree
  • Experience in a pharmaceutical or biotechnology firm

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery accelerates precision biologics development, enhancing treatment options.
  • Partnership with Danaher advances precision medicine diagnostics, improving patient outcomes.
  • $300 million Rockville facility expands AstraZeneca's cell therapy capabilities.

What critics are saying

  • Increased competition in AI-driven drug discovery may impact AstraZeneca's market position.
  • Regulatory challenges in the EU could delay Imfinzi's market entry for bladder cancer.
  • Geopolitical risks in Beijing may affect AstraZeneca's strategic R&D center operations.

What makes AstraZeneca unique

  • AstraZeneca's Open Innovation program accelerates drug discovery through shared resources.
  • The A.Catalyst Network connects global health innovation hubs for collaborative advancements.
  • Strategic partnerships enhance AstraZeneca's research capabilities and product portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL

Business Weekly
Jun 5th, 2025
Sortera Bio secures £7.5m pre-seed funding

Sortera Bio, a Cambridge biotech, secured a £7.5m pre-seed round led by Cambridge Innovation Capital, with AstraZeneca and BioNTech participating. The funding will enhance Sortera's Deep Screening platform, which uses AI for drug discovery. Co-founded by Dr. Ben Porebski and Dr. Philipp Holliger, Sortera aims to deliver precision biologics. The technology was developed at the MRC Laboratory of Molecular Biology with AstraZeneca's support.

Pharmashots
Jun 2nd, 2025
AstraZeneca Presents P-III (MATTERHORN) Trial Data of Imfinzi as Perioperative Therapy for G/GEJ Cancers at ASCO 2025

AstraZeneca has shared P-III (MATTERHORN) trial data assessing perioperative Imfinzi + FLOT (n=474) vs PBO + FLOT (n=474) in 948 pts with stage II-IVA G/GEJ cancers at ASCO 2025

Cision
Jun 2nd, 2025
Block Listing Interim Review

2 June 2025 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris. (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 2 June 2025 Name of applicant: ASTRAZENECA PLC Name of scheme: ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS -RELATED SHARE OPTION PLAN;

360Dx
May 30th, 2025
Danaher, AstraZeneca Partner to Develop Novel Precision Medicine Diagnostics

NEW YORK - Danaher announced Thursday that it is partnering with AstraZeneca to develop and commercialize novel diagnostic tests for precision medicine patients.